These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20459387)

  • 1. Genetic databases and their potential in pharmacogenomics.
    Lagoumintzis G; Poulas K; Patrinos GP
    Curr Pharm Des; 2010; 16(20):2224-31. PubMed ID: 20459387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biostatistic tools in pharmacogenomics--advances, challenges, potential.
    Sato Y; Laird NM; Yoshida T
    Curr Pharm Des; 2010; 16(20):2232-40. PubMed ID: 20459388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future prospects for pharmacogenetics in the quest for personalized medicine.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenes (PGx-genes): Current understanding and future directions.
    Katara P; Yadav A
    Gene; 2019 Nov; 718():144050. PubMed ID: 31425740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico dynamic molecular interaction networks for the discovery of new therapeutic targets.
    Vujasinovic T; Zampera AS; Jackers P; Sanoudou D; Depaulis A
    Curr Pharm Des; 2010; 16(20):2241-51. PubMed ID: 20459389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics knowledge for personalized medicine.
    Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
    Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics, precision medicine, and implications for anesthesia care.
    Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering next-generation pharmacogenomics: an information technology perspective.
    Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
    Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
    Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Therapeutics and Pharmacogenomics: Integral to Personalized Health Care.
    Sadee W
    Pharm Res; 2017 Aug; 34(8):1535-1538. PubMed ID: 28493098
    [No Abstract]   [Full Text] [Related]  

  • 14. SNP web resources and their potential applications in personalized medicine.
    Wang J; Pang GS; Chong SS; Lee CG
    Curr Drug Metab; 2012 Sep; 13(7):978-90. PubMed ID: 22591348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic insights into depression and antidepressant response: does sex matter?
    Pitychoutis PM; Zisaki A; Dalla C; Papadopoulou-Daifoti Z
    Curr Pharm Des; 2010; 16(20):2214-23. PubMed ID: 20459391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine.
    Mitropoulos K; Innocenti F; van Schaik RH; Lezhava A; Tzimas G; Kollia P; Macek M; Fortina P; Patrinos GP
    Pharmacogenomics; 2012 Mar; 13(4):387-92. PubMed ID: 22379996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacogenomics genomics approaches to optimizing drug therapy].
    Shi J; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacogenetics in oncology: the paradigm of molecular targeted therapies.
    Mountzios G; Sanoudou D; Syrigos KN
    Curr Pharm Des; 2010; 16(20):2184-93. PubMed ID: 20459386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.